Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy

We present 2 patients with metastatic colorectal cancer who had progressed despite treatment with first-line FOLFOX and second-line FOLFIRI combination chemotherapy regimens. After failing these fluoropyrimidine-based regimens, both patients received additional cytotoxic and targeted therapies with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Biol Ther
Asıl Yazarlar: Marks, Eric I., Tan, Carlyn, Zhang, Jun, Zhou, Lanlan, Yang, Zhaohai, Scicchitano, Angelique, El-Deiry, Wafik S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Bedside to Bench Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847811/
https://ncbi.nlm.nih.gov/pubmed/26561209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1113355
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller